当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Osimertinib for leptomeningeal metastases in NSCLC.
The Lancet Oncology ( IF 41.6 ) Pub Date : 2019-12-12 , DOI: 10.1016/s1470-2045(19)30810-1
Elizabeth Gourd

Osimertinib showed antitumour activity in the CNS of patients with EGFR-mutated advanced non-small-cell lung cancer (NSCLC) and leptomeningeal metastases, according to a recent study.

中文翻译:

奥西替尼用于NSCLC中的软脑膜转移。

根据最近的一项研究,奥西替尼在具有EGFR突变的晚期非小细胞肺癌(NSCLC)和软脑膜转移的患者的中枢神经系统中显示出抗肿瘤活性。
更新日期:2020-01-04
down
wechat
bug